Noninvasive Glucose Gets Stuck

Noninvasive Glucose Gets Stuck

Noninvasive researchers run aground in the phase in which the technology is to be presented to peers, with one or more convincing experiments that can be repeated and withstand technical challenges.

The De Novo summary for the Dexcom G6, DEN170088, is an excellent outline for noninvasive researchers to model in presenting convincing data if the stated objective is continuous glucose monitoring for people with diabetes. If there is no stated objective or indications for use statement, the effort is research, not R&D.

Questions probing the veracity of a noninvasive adventure may include, "What specific regulation will the product meet?"

Mark Tapsak

Chief Scientific Officer at Glucotrack Inc (Nasdaq: GCTK), CEO of Tapsak Enterprises LLC

1 年

Well said James.

要查看或添加评论,请登录

James Causey的更多文章

  • Listen to Patients, Each Are Unique

    Listen to Patients, Each Are Unique

    The FDA approves device technologies based on aggregated clinical experiences. Sponsors of integrated continuous…

  • Insulin Pumps Under Pressure

    Insulin Pumps Under Pressure

    FDA recall number: Z-1266-2025. Approximately 329,000 affected pumps are in commerce.

    5 条评论
  • A Medtronic Class II Recall Posted 03/03/2025

    A Medtronic Class II Recall Posted 03/03/2025

    "All Medtronic MiniMed pumps (Paradigm series, Minimed 530G, 6XX series, and 7XX series) were found to have the…

    2 条评论
  • Continuous Glucose Monitors: There Are Issues

    Continuous Glucose Monitors: There Are Issues

    The sponsors of integrated continuous glucose monitors (iCGMs), the FDA's naming for sensors that meet 21 CFR 862.1355,…

    3 条评论
  • Noninvasive Glucose: Not For Dosing Insulin

    Noninvasive Glucose: Not For Dosing Insulin

    Is there a role for glucose insights that do not mirror the sensitivity and specificity of the electrochemical…

  • The Insulin Pump Hardware is the Easy Part

    The Insulin Pump Hardware is the Easy Part

    Becoming an insulin pump company is not easy, quick, or inexpensive. Disassemble an Insulet Omnipod 5 and marvel at how…

    1 条评论
  • A David Kliff and Jim Causey Collaboration

    A David Kliff and Jim Causey Collaboration

    We have converged our insights to connect the dots and look beyond the obvious. The report is more than 75 pages and…

  • Door #1 or Door #2?

    Door #1 or Door #2?

    The Insulet/EOFlow/Medtronic drama may have a new chapter. Medtronic wanted EOFlow.

  • "Time in Range" Impacted by iCGM Error

    "Time in Range" Impacted by iCGM Error

    Integrated continuous glucose monitors (iCGMs) earn FDA clearance by clinical demonstration of meeting the Special…

    5 条评论
  • A Kobayashi Maru for Noninvasive Glucose

    A Kobayashi Maru for Noninvasive Glucose

    Is near-infrared the right spectrum segment sensitive to glucose in a wearable? Yes. Has any method attempted with a…

社区洞察

其他会员也浏览了